Multicenter analysis of soluble Axl reveals diagnostic value for very early stage hepatocellular carcinoma. - Wikidata - awgldk - TriplyDB

Multicenter analysis of soluble Axl reveals diagnostic value for very early stage hepatocellular carcinoma.

Multicenter analysis of soluble Axl reveals diagnostic value for very early stage hepatocellular carcinoma.

http://www.wikidata.org/entity/Q35669106

about

Biomarkers for the early diagnosis of hepatocellular carcinoma The Receptor Tyrosine Kinase AXL in Cancer Progression Molecular Pathways: AXL, a Membrane Receptor Mediator of Resistance to Therapy Circulating predictive and diagnostic biomarkers for hepatitis B virus-associated hepatocellular carcinoma A rapid in vivo screen for pancreatic ductal adenocarcinoma therapeutics.Neuropilin-2 induced by transforming growth factor-β augments migration of hepatocellular carcinoma cells.Screening for hepatocellular carcinoma and cholangiocarcinoma: Can biomarkers replace imaging?Axl Expression Stratifies Patients with Poor Prognosis after Hepatectomy for Hepatocellular Carcinoma.Characterization of site-specific glycosylation of secreted proteins associated with multi-drug resistance of gastric cancer.Accuracy of novel diagnostic biomarkers for hepatocellular carcinoma: An update for clinicians (Review)Axl and Mer Receptor Tyrosine Kinases: Distinct and Nonoverlapping Roles in Inflammation and Cancer?Soluble Axl is an accurate biomarker of cirrhosis and hepatocellular carcinoma development: results from a large scale multicenter analysis.The non-invasive serum biomarker soluble Axl accurately detects advanced liver fibrosis and cirrhosis.Function of Axl receptor tyrosine kinase in non-small cell lung cancer.Dynamics of CRISPR/Cas9-mediated genomic editing of the AXL locus in hepatocellular carcinoma cells.Molecular Pathways: Receptor Ectodomain Shedding in Treatment, Resistance, and Monitoring of Cancer.

P2860

Q26784418-B4B4314D-3BCC-4C51-B983-1599C940C39D Q28068756-51A2E82E-EC82-42FE-B963-DB265399AB47 Q28070028-7BD5D789-A058-4ED5-BA8F-C1D7FE54C9D4 Q28080175-B0B0335C-03AA-468A-97BA-349584518588 Q30669159-0090A821-6589-4606-9C3A-25296203FC8D Q35843159-AAC975FE-6AF3-4657-BB0B-1E20D074F2DC Q36000994-6D84F057-2D64-486A-9E53-EEEDB47CDC6D Q36018500-23F4D3A9-52F6-49C1-87A7-0FCC45E87728 Q37295326-EB04F865-BE7F-44E5-BB8A-1CEBCA603DDD Q38859488-F44198AE-8625-4ED7-81C7-BDAB1CD44521 Q38936702-905E5B0B-6D63-4254-BAC4-97E491E9D442 Q40193396-ADD475DE-2FCB-4D17-B23B-C59C2D1A1EAF Q47133471-7DFF0967-9B44-4754-830A-5CE4BCAE2678 Q49636410-545A6DD7-0132-4939-B055-004C7C821B8C Q49731474-B402C971-48F0-4BAF-BCF5-39619D199504 Q51091805-393D6C53-445E-42CC-AC36-393693AF2696

P2860

Multicenter analysis of soluble Axl reveals diagnostic value for very early stage hepatocellular carcinoma.

http://www.wikidata.org/entity/Q35669106

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Multicenter analysis of solubl ...... tage hepatocellular carcinoma.

@ast

Multicenter analysis of solubl ...... tage hepatocellular carcinoma.

@en

type

label

Multicenter analysis of solubl ...... tage hepatocellular carcinoma.

@ast

Multicenter analysis of solubl ...... tage hepatocellular carcinoma.

@en

prefLabel

Multicenter analysis of solubl ...... tage hepatocellular carcinoma.

@ast

Multicenter analysis of solubl ...... tage hepatocellular carcinoma.

@en

P1433

Q35669106-E49C9DDB-0BD7-46A2-A949-11294DF76508

P1476

Q35669106-EE8FC4F6-6CE5-4BDB-B55C-696D62093466

P2093

Q35669106-07321BD7-678C-4DC2-9829-9AE57162E7B1

Q35669106-0DF98253-D7FC-4F56-9E49-BF687658FBF7

Q35669106-2106C870-933C-4484-A7FE-EF2EE6BECF22

Q35669106-3A8B2555-10CB-48F5-B83B-20ED6C8EE0EA

Q35669106-408F2322-FCCD-4624-85CB-49217396851F

Q35669106-55329EBF-0578-4394-A7E5-04599F6B4F0A

Q35669106-9884A857-28F7-41F5-8949-0A21CF6E739C

Q35669106-99346F88-C950-405E-9DCC-18366A26E980

Q35669106-A6E0FE0F-3EC1-4375-905A-8EBFE7B2C9D2

Q35669106-B60144AF-4B79-488F-B100-E96C420041F0

P2860

Q35669106-107DF96C-3579-4AD0-93A3-969A5B8B5B39

Q35669106-188C4B18-9A07-442A-80C5-F19B375FCA98

Q35669106-1E632B3E-DF7E-4CCC-A137-6A2A0B3C955B

Q35669106-1FE6DCE6-886C-40F9-9498-109D12E70142

Q35669106-2DAF60FD-142A-4A49-8AAB-437EEF5B9680

Q35669106-2EEE02A1-ED4E-4017-ABFA-B459FB8463B1

Q35669106-3638AEEF-5938-4D68-90F5-A67F3C425E20

Q35669106-3F531CD2-9364-4C26-985D-0806AE815347

Q35669106-4542D8C2-6BCC-48B7-B802-77C03F08CA53

Q35669106-47F39B95-0247-4A4E-B304-F9B1C7940703

P304

Q35669106-7ACDF2EB-5638-406E-9A04-D21E875DB7FE

P31

Q35669106-9C72DDF6-9634-42D8-87EF-D4079E2671F2

P356

Q35669106-16044752-1B4A-494C-A0E9-495FEB3726A2

P433

Q35669106-40DFEF43-042F-42F0-BA81-A851F7A36801

P478

Q35669106-F73C2435-AF56-43DA-B759-450AF499D71C

P50

Q35669106-034EFAE1-6845-48F0-8337-081E4A54D17A

Q35669106-5588B1A4-5079-4895-B79C-933A24B0C9D1

Q35669106-80E15D98-9635-4B10-83E1-92657E3A8E95

Q35669106-C8E4058D-654C-45FE-89DA-3B4A720D4113

Q35669106-D7F16C4D-A97C-40C0-B0A2-C6DA236C7DF9

P577

Q35669106-46F0C481-B17F-45F2-A36D-922E921413ED

P5875

Q35669106-1F323121-BCAC-43E1-A00E-50548F748C13

P698

Q35669106-D15492E2-46CE-4F2F-848E-1ED0285F4BDB

P921

Q35669106-763A078D-FEC0-47E4-9164-22E01CAE36B7

P932

Q35669106-56B1A17E-D62A-404C-BCB7-6420FFE6291B

P356

P1433

International Journal of Cancer

P1476

Multicenter analysis of solubl ...... stage hepatocellular carcinoma

@en

P2093

Chun Fang Gao

http://www.w3.org/2001/XMLSchema#string

Dalibor Valik

http://www.w3.org/2001/XMLSchema#string

Jiayun Shen

http://www.w3.org/2001/XMLSchema#string

Jun Yu

http://www.w3.org/2001/XMLSchema#string

Katharina Staufer

http://www.w3.org/2001/XMLSchema#string

Kristina Greplova

http://www.w3.org/2001/XMLSchema#string

Kwan Man

http://www.w3.org/2001/XMLSchema#string

Meng Fang

http://www.w3.org/2001/XMLSchema#string

Michael Trauner

http://www.w3.org/2001/XMLSchema#string

Patrick Reichl

http://www.w3.org/2001/XMLSchema#string

P2860

Gas6 is complexed to the soluble tyrosine kinase receptor Axl in human blood

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

Hepatocellular carcinoma in cirrhosis: incidence and risk factors

The transforming receptor tyrosine kinase, Axl, is post-translationally regulated by proteolytic cleavage

Prognosis of hepatocellular carcinoma: the BCLC staging classification

Parallel hybridization analysis of multiple protein kinase genes: identification of gene expression patterns characteristic of human hepatocellular carcinoma.

Axl is an essential epithelial-to-mesenchymal transition-induced regulator of breast cancer metastasis and patient survival.

Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials.

Meta-analysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis.

Evaluating patients with cirrhosis for hepatocellular carcinoma: value of clinical symptomatology, imaging and alpha-fetoprotein.

P304

385-394

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/IJC.29394

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

137

http://www.w3.org/2001/XMLSchema#string

P50

Christine Brostjan

Wolfgang Mikulits

Patrick Starlinger

P577

2015-01-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

269776636

http://www.w3.org/2001/XMLSchema#string

P698

25529751

http://www.w3.org/2001/XMLSchema#string

P921

multicenter trial

P932

4450342

http://www.w3.org/2001/XMLSchema#string